Skip to main content
Become a Member
(402) 474-4472
  • Login
 
 
  • About
    • Officers
    • ASCO in Action
    • Latest News & Therapies
  • Clinical Trials
    • For Patients
    • For Physicians
  • Events
  • Membership
    • Membership Application
    • Corporate Membership
  • Contact
Nebraska Oncology Society - Connecting the Oncology Community
 
 
Connecting the Oncology Community
 
 

Nebraska Oncology Society

Nebraska Oncology Society is a non-profit organization that has been in existence since 1992.  Our mission is to facilitate and promote interaction among the oncology community to enhance patient care through oncology research, education, and health care legislation.

We invite you to become involved!

 
 

New Clinical Trials

VIEW ALL CLINICAL TRIALS
Study of Venetoclax (ABT199) Plus Chemoimmunotherapy for MYC/BCL2 Double-Hit and Double Expressing Lymphomas (A051701)
Phase II
LEARN MORE
Study of pembrolizumab with or without lenvatinib to evaluate the safety and efficacy of pembrolizumab and lenvatinib as 1L intervention in a PD-L1 population with recurrent or metastatic head and neck squamous cell carcinoma(LEAP010)
LEARN MORE
A study of MGA271 in Combination with pembrolizumab and in combination with MGA012 in Patients with Melanoma, Squamous Cell Cancer of the Head and Neck, Non-Small Cell Lung Cancer, Urothelial Cancer, and other cancers (CP-MGA271-03)
Phase I
LEARN MORE
VIEW ALL CLINICAL TRIALS
 
  • Events
  • News
 
Become a NOS Member Today!
Join Now
 

Platinum Corporate Members

Gold Corporate Members

 
Nebraska Oncology Society
1045 Lincoln Mall, Suite 200
Lincoln, NE 68508
\\
carmencg@nebmed.org
\\
402-474-4472
 
 
  • About
    • Officers
    • ASCO in Action
    • Latest News & Therapies
  • Clinical Trials
    • For Patients
    • For Physicians
  • Events
  • Membership
    • Membership Application
    • Corporate Membership
  • Contact
 
 
 2023

Nebraska Oncology Society

  |   Website Design & Development by UNANIMOUS